506U78 in Treating Patients With Lymphoma

NCT00005080 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

NIH

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Recurrent Adult T-cell Leukemia/Lymphoma
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Recurrent Mycosis Fungoides/Sezary Syndrome
Small Intestine Lymphoma
Stage I Cutaneous T-cell Non-Hodgkin Lymphoma
Stage I Mycosis Fungoides/Sezary Syndrome
Stage II Cutaneous T-cell Non-Hodgkin Lymphoma
Stage II Mycosis Fungoides/Sezary Syndrome
Stage III Cutaneous T-cell Non-Hodgkin Lymphoma
Stage III Mycosis Fungoides/Sezary Syndrome
Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
Stage IV Mycosis Fungoides/Sezary Syndrome

Interventions

DRUG: nelarabine

Sponsor

National Cancer Institute (NCI)